Related references
Note: Only part of the references are listed.Hypothyroidism in Patients With Renal Cell Carcinoma Blessing or Curse?
Manuela Schmidinger et al.
CANCER (2011)
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Kristy J. Gotink et al.
ANGIOGENESIS (2010)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The clinical implications of sunitinib-induced hypothyroidism:: a prospective evaluation
P. Wolter et al.
BRITISH JOURNAL OF CANCER (2008)
Documentation of Thyroid Function in Clinical Studies With Sunitinib: Why Does It Matter?
David H. Garfield et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data
Hans C. van Houwelingen et al.
LIFETIME DATA ANALYSIS (2008)
Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies
Doru T. Alexandrescu et al.
THYROID (2008)
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake
Deborah Mannavola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
Darren R. Feldman et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
David H. Garfield et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity
Elaine Wong et al.
THYROID (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
Brian I. Rini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors
Jayesh Desai et al.
ANNALS OF INTERNAL MEDICINE (2006)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Association between development of hypothyroidism and improved survival in patients with head and neck cancer
Marc Nelson et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: Toward a new classification
JC Mandac et al.
HEPATOLOGY (2006)
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
T Kamba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Thyroid hormone and breast carcinoma - Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma
M Cristofanilli et al.
CANCER (2005)
Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society
H Gharib et al.
THYROID (2005)
Subclinical thyroid disease - Scientific review and guidelines for diagnosis and management
MI Surks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Share Paper
